pascolizumab pascolizumab pascolizumab is a humanized monoclonal antibody for the treatment of asthma. a phase ii clinical trial in patients with symptomatic glucocorticoid naive asthma has been conducted in 2001/2002. pascolizumabmonoclonal antibodytypewhole antibodysourcehumanized (from mouse)targetil-4clinical dataatc codenoneidentifierscas number331243-22-2 niuphar/bps7786chemspidernoneuniin1ioa09r6a ny (what is this?) (verify)